Probably Genetic Awarded Up to $10M ARPA-H Contract to End the Rare Disease Diagnostic Odyssey with AI

Probably Genetic Awarded Up to $10M ARPA-H Contract to End the Rare Disease Diagnostic Odyssey with AI

PR Newswire

SAN FRANCISCO, Aug. 31, 2026

Part of the RAPID program, Probably Genetic will scale patient-driven AI platform to accelerate rare disease diagnosis, research, and treatmentSAN FRANCISCO, Aug. 31, 2026 /PRNewswire/ -- Probably Genetic, the AI platform powering the research, diagnosis, and treatment of genetic diseases, has been awarded up to $10 million from the Advanced Research Projects Agency for Health (ARPA-H), a U.S. federal agency within the Department of Health and Human Services (HHS) that funds high-risk, high-reward, and transformative biomedical research. As part of ARPA-H's Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program, Probably Genetic will leverage and build upon its rich dataset to aggregate data directly from patients and caregivers, revealing patterns that will dramatically reduce the diagnostic odyssey faced by rare disease patients. Beyond diagnosis, this data will form the backbone of multi-omic phenotype models that link real-world evidence to disease biology and give drug developers insights needed to identify targets, stratify patients, and design clinical trials.